JAMA Internal Medicine
@jamainternalmed
JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
ID: 54664757
http://jamainternalmed.com 07-07-2009 20:26:59
29,29K Tweet
108,108K Followers
515 Following
Most viewed in the last 7 days from JAMA Internal Medicine: How effective are scalable, relatively low-resource mindfulness-based interventions delivered via telehealth for veterans with chronic pain? ja.ma/3YV3NUw
Exhibits at #ESCCongress 2024 are open. Find JAMA, JAMA Cardiology, JAMA Internal Medicine, and JAMA Network Open at booth G190. Get recent articles, find out when you can meet our editors, and ask us about publishing opportunities and submitting your work
Attending #ESCCongress? Check out our page created for attendees. Get recent articles, find out when you can meet our editors, and get information For Authors on JAMA, JAMA Cardiology, JAMA Internal Medicine, and JAMA Network Open ja.ma/4783h7N
Most viewed in the last 7 days from JAMA Internal Medicine: Viewpoint discusses challenges posed by religious hospital monopolies for patients who do not share the same faith. ja.ma/3AGMGeR
Viewpoint by Sam Doernberg, Barak Richman, & Lauren Taylor discusses challenges posed by religious hospital monopolies for patients who do not share the same faith. ja.ma/3MmyJWb
Viewpoint by Lisa Simon discusses how dentists could provide some primary health care services as part of an interdisciplinary team, easing the burden on clinicians. ja.ma/3SxHtwb The Santa Fe Group
Attending #ESCCongress? Read the latest cardiology research published in JAMA, JAMA Cardiology, JAMA Internal Medicine, JAMA Network Open, and our other JAMA Network journals for free by signing up for weekly email alerts through our web site ja.ma/3T4L6dm
Thinking about submitting your #ESCCongress research to JAMA, JAMA Cardiology, JAMA Internal Medicine, JAMA Network Open, or one of our other Network journals? This video tells you what to expect from the submission and review process ja.ma/3Td0l3N
A new study, led by Thomas Wadden, PhD, finds taking #semaglutide for weight management does not increase risk of #depression or suicidal behavior in people without known major psychopathology. JAMA Internal Medicine spr.ly/6011mAINW
📢No increased risk of suicide after GLP-1 use! Our new 🇸🇪🇩🇰 study out in JAMA Internal Medicine ▶️300,000 users of GLP-1 and SGLT-2 ▶️2.5 yrs avg follow-up ▶️HR 1.25 (0.83 to 1.88) ▶️Also no increased risk of self-harm, depression and anxiety. LINK below🧵
Most viewed in the last 7 days from JAMA Internal Medicine: Viewpoint discusses challenges posed by religious hospital monopolies for patients who do not share the same faith. ja.ma/3T9qT5T